Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company, headquartered in Saudi Arabia, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality healthcare products. Established in 1991, the company has achieved significant milestones, including the expansion of its operational regions across the Middle East and North Africa. Jamjoom Pharmaceuticals is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and nutraceuticals. What sets the company apart is its commitment to innovation and quality, ensuring that all products meet stringent international standards. With a strong market position, Jamjoom Pharmaceuticals has garnered numerous accolades for its contributions to healthcare, solidifying its reputation as a trusted name in the industry.
DitchCarbon Score
How does Jamjoom Pharmaceuticals Factory Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jamjoom Pharmaceuticals Factory Company's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jamjoom Pharmaceuticals Factory Company's reported carbon emissions
In 2024, Jamjoom Pharmaceuticals Factory Company reported significant carbon emissions, totalling approximately 7,248,000 kg CO2e for Scope 1 and about 19,983,000 kg CO2e for Scope 2. This data reflects their operational impact on climate change, with a combined total of about 27,231,000 kg CO2e from direct and indirect emissions. The company has not disclosed any Scope 3 emissions data, which typically includes emissions from the supply chain and product use. Additionally, there are no specific reduction targets or climate pledges outlined in their sustainability initiatives for the year. Jamjoom Pharmaceuticals operates within Saudi Arabia and has reported a greenhouse gas emissions intensity of 0.18 tonnes CO2e per unit of revenue, indicating their emissions relative to financial performance. However, without established reduction targets or commitments, the company’s future climate strategy remains unclear. Overall, while Jamjoom Pharmaceuticals has made strides in reporting their emissions, further commitments and initiatives will be essential for enhancing their sustainability profile and addressing climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 7,248,000 |
| Scope 2 | 19,983,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jamjoom Pharmaceuticals Factory Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
